Antipsychotics, mood stabilizers, etc.
PreclinicalSmall molecule
Antipsychotics, mood stabilizers, etc. is one of 13 small molecule programs targeting Major Depressive Episode. It is currently in Preclinical.
1
Indications
2
Total Trials
1
Active Trials
12
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
13 competitors in Major Depressive Episode
#DrugCompanyPhaseTrials
1Ketalar
AAultman Health Foundation
Approved
Vimpat
UCBPhase 3
Brintellix
TakedaPhase 3
Abilify
OtsukaPhase 3
Suboxone
IIndivior Inc.
Phase 3
FK949E
AstellasPhase 3
SAGE-217
BiogenPhase 2
Lithobid
SSolvay Pharmaceuticals
Preclinical
SEP-4199
Sumitomo Pharma America, Inc.Phase 2
MAP4343
TThe Scripps Research Institute
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details